INTRODUCTION
According to a report by the World Health Organization (WHO), Africa's population is ageing, with a substantial increase of the absolute number of older people (from 7.4 million in 2005, to 193 million by 2050). Life expectancy at age 60 is 15 years for men, and 17 years for women. 1 The number of hip arthritis and hip fractures will also increase, and the ability to appropriately treat these patients will became a matter of public health. Total hip replacement (THR) is the gold-standard treatment for both hip arthritis and displaced femoral neck fractures in active, elderly patients who are community ambulators. 2 Cape Verde is a West African country with a growing economy. It graduated from the group of least developed countries in 2008. However, it still benefits from a strong health cooperation agreement with Portugal.
Regarding total hip replacement (THR), Cape Verde struggles with the absence of instruments and implants, although it has skilled personnel and suitable infrastructures. Thereby, all Cape Verdean patients with hip arthritis have to go through a slow and laborious evacuation process to Portugal. Patients with hip fractures, even those with a formal indication for THR, undergo the only treatments available in Cape Verde: hemiarthroplasty or internal fixation. The cost of the evacuation and treatment of these patients is partially supported by both countries. According to the existing law (decree-law no. 24/77, of 3 rd of March, and decree-law no. 129/80, of 18 th of November), Cape Verde is responsible for paying the patients' trips, accommodation and medication, while Portugal is in charge of the payment of all medical care expenses.
The purpose of this study was to conduct a cost-benefit analysis on the enablement of Cape Verde to autonomously perform THR, meaning providing one set of instrumental and the implants needed for the projected number of cases.
MATERIAL AND METHODS

Data collection
In order to define the study sample, we have retrospectively assessed:
-All cases of displaced hip fracture included in the medical records of the Orthopaedic Department of São Vicente -Cape Verde. -All arthritis cases referred for evacuation from Cape Verde to Portugal due to THR included in the Portuguese Directorate-General of Health records. We have studied the period from 2011 to 2016. Patients with hip fracture without indication for THR (considering age and co-morbidities), and those with an evacuation request denied were excluded. The patients who were evacuated with bilateral hip arthritis were included twice in the cost calculation. A total of 126 patients (135 hips) met these criteria, and formed the sample (hip fractures n = 43; hip arthritis n = 92).
Data on costs came from the financial departments of Dr Baptista de Sousa Hospital, the Portuguese Ministry of Health, the Portuguese Embassy in Cape Verde, and surgical implant suppliers.
We assessed all the direct costs associated with the treatment of hip fracture in Cape Verde, according to the Hospital's financial department. The costs included hospitalisation and surgery (Table 1 ). Although THR is not performed in Cape Verde, the financial department has a predictable cost for the procedure.
For those with hip arthritis (treated in Portugal under the evacuation protocol) the costs included: clinical appointments, hospitalisation, surgery, post-operative medication, and daily stipend ( Table 2 ). These costs fluctuate according to the year and the hospital responsible for performing the surgery.
The enablement of Cape Verde to autonomously perform THR is associated with the direct cost of the necessary instruments and of the THR implants. Other hypothetical costs are also involved: appointments, hospitalisation, and surgery.
Indirect costs related with quality of life, absenteeism, and psychological issues as a result of undergoing surgery abroad were not included.
Database management ensured patient anonymity and confidentiality, and fully complied with Caldicott principles.
The data was anonymised and none of the authors had access to patient identification. The authors have followed the protocols of their work center on the publication of data.
Study design and data analysis
We performed a cost-benefit analysis on the enablement of Cape Verde to autonomously perform THR in cases of hip fracture and arthritis. The reference for comparison was the present treatment situation, which included treating hip fractures in Cape Verde, and hip arthritis in Portugal. For the hip fracture the costs included: initial hospitalisation fee, fee per day of hospitalisation, surgery, and two follow-up appointments.
For hip arthritis, the design of the study established: 60 days of stay in Portugal, one first Orthopedic surgery and an Anaesthesia appointment, two follow-up Orthopedic Surgery appointments, and 30 days of post-operative analgesic medication (40 pills of paracetamol 1000 mg, and 40 pills of dipirone 575 mg), as well as anti-thrombotic medication (low molecular weight heparin 40 mg).
We have calculated the direct cost of the treatment of our sample and hypothesised the cost of the enablement of Cape Verde to autonomously perform THR on the same number of patients. For this calculation, we considered: one first Orthopedic surgery and Anaesthesia appointment, two follow-up Orthopedic surgery appointments, the average duration of hospitalisation at the São Vicente Orthopaedic department, the purchase cost of the instruments (€80 000), and implants per patient (€1300). The cost of the instruments and implants are an informal estimation provided by a major medical company. The cost of medication was not taken into consideration because without the evacuation protocol, the patients would bear it.
The primary outcome measure was the cost or benefit per patient over a 6-year period. All costs and benefits were converted to Euros.
Data collection limitations
The present study presents some limitations regarding the data collection. It was not possible to include the cost of evacuation. It was not possible to ascertain the cost of performing THR in 2011 and 2012 at Centro Hospitalar Universitário de Coimbra, and in 2011 at Centro Hospitalar Lisboa Ocidental. For the THR performed at these Centres, we have replaced the missing values with the cost of performing THR during the following year (Table 2) .
RESULTS
Between 2011 and 2016, the Orthopaedic Department of São Vicente -Cape Verde treated 43 patients with hip fracture and a formal indication for THR (Table 3 ). The average age of the patients was 63.1 years (min. 36; max. 75, median 66); 18 patients were females, and 25 were males. In 28 of the cases, the treatment option was hemiarthroplasty; in 10 cases, internal fixation was performed; and 5 cases were treated conservatively. There were 841 days of hospitalisation in total. The average of the hospitalisation duration was 19.3 days (min. 5, max. 74, median 16). The total cost of treatment was €43 589.71.
During the same period of time, 83 patients were evacuated to Portugal in order to undergo THR, 9 of them bilateral (n = 92 hips) ( Table 4 ). The average age of the patients at the time of the referral was 50.5 (min. 17; max. 86, median 53), and 31 patients were female, while 52 were male. A total of €441 791.17 was spent in the treatment of these patients. The global cost of treatment of both hip arthritis and fractures is €485 380.88.
Considering the hypothesis of performing 135 THRs in Cape Verde, which would mean 126 patients would be treated avoiding evacuation, a total sum of €404 736.80 would be spent (Table 5) . Compared with the present situation, enabling Cape Verde to perform THR would result in a global benefit of €80 644.08, and a benefit of €597.36/per patient over a 6-year period.
DISCUSSION
The global burden of musculoskeletal disease in low and middle-income countries is large, growing, and neglected.
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Half of the world's population lacks access to adequate primary healthcare, and two thirds lack access to orthopaedic care. 4 To the best of our knowledge, there are no published papers regarding the cost-effectiveness of performing THR in middle-income countries. Cape Verde differs from the rest of the Portuguese-speaking African countries that benefit from the health agreement with Portugal, as it is a middleincome country, and thus it has reasonable infrastructures and trained surgeons capable of offering good healthcare services to its population. Nunes Our analysis indicates that enabling Cape Verde to autonomously perform THR on patients with hip fracture and arthritis would have a positive financial return, since it would represent savings of €597.36/per patient over a 6-year period. This analysis included one of the two Orthopaedic departments in the country. São Vicente Orthopaedic Department serves 167 658 of the 491 575 inhabitants, meaning that these results would be even more expressive if we considered the whole population of the country. 5 It should be taken into account that this is also an important focus for investment since we now witness a growing life expectancy, hence, an increase of the problem. The cost of evacuation is an important financial burden that was not possible to include in the current study. This limitation underestimates the benefit of the enablement of Cape Verde to perform THR. Indirect costs like the psychological burden and the quality of life of those who have to undergo an unsatisfactory treatment, or those who have to be evacuated and undergo surgery in a foreign country, were not taken into account. There are some other important aspects resulting from the enablement of Cape Verde to perform THR: we believe that an increase in patients' satisfaction and quality of life is expectable, as well as a decrease in absenteeism in the workplace. All these situations contribute to value the benefit of this adjustment.
The current situation is, of course, the result of a longterm and well established but outdated agreement between Portugal and Cape Verde. Any changes to that agreement have to be carried out with sensitivity and responsibility from both political sides, and before definitely changing the current situation, it would be important to establish a trial phase.
CONCLUSION
Compared with the present situation, enabling Cape Verde to perform THR would result in a global benefit per patient over a 6-year period, while improving the quality of healthcare and autonomy in the country. Nevertheless, the changes to the outdated political agreement with Portugal have to be made cautiously, in order to promote higher quality and fairer healthcare. 
